Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumio Ohtsuki

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
Biological & Pharmaceutical Bulletin|October 7, 2004
New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous systemSumio Ohtsuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2004
[Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system]Sumio Ohtsuki
Vitamins and Hormones|July 19, 2024
Insulin receptor at the blood-brain barrier: Transport and signalingSumio Ohtsuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2012
[Pharmacoproteomic approach by quantitative targeted proteomics]Sumio Ohtsuki
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodologyTetsuya Terasaki, Sumio Ohtsuki
Pharmaceutical Research|July 11, 2007
Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and developmentSumio Ohtsuki, Tetsuya Terasaki
Biological & Pharmaceutical Bulletin|November 5, 2025
Inhibitory Effect of Insulin-Degrading Enzyme-Selective Inhibitor, Ii1, on the Elimination of Amyloid-β(1-40) from Rat BrainTakeshi Shiiki, Sumio Ohtsuki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 5, 2003
[Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier]Sumio Ohtsuki, Satoko Hori, Tetsuya Terasaki
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2014
Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment modelsYasuo Uchida, Sumio Ohtsuki, Tetsuya Terasaki
Neuroscience Research|August 24, 2006
Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrierShingo Ito, Sumio Ohtsuki, Tetsuya Terasaki
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
Biological & Pharmaceutical Bulletin|October 7, 2004
New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous systemSumio Ohtsuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2004
[Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system]Sumio Ohtsuki
Vitamins and Hormones|July 19, 2024
Insulin receptor at the blood-brain barrier: Transport and signalingSumio Ohtsuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2012
[Pharmacoproteomic approach by quantitative targeted proteomics]Sumio Ohtsuki
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodologyTetsuya Terasaki, Sumio Ohtsuki
Pharmaceutical Research|July 11, 2007
Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and developmentSumio Ohtsuki, Tetsuya Terasaki
Biological & Pharmaceutical Bulletin|November 5, 2025
Inhibitory Effect of Insulin-Degrading Enzyme-Selective Inhibitor, Ii1, on the Elimination of Amyloid-β(1-40) from Rat BrainTakeshi Shiiki, Sumio Ohtsuki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 5, 2003
[Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier]Sumio Ohtsuki, Satoko Hori, Tetsuya Terasaki
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2014
Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment modelsYasuo Uchida, Sumio Ohtsuki, Tetsuya Terasaki
Neuroscience Research|August 24, 2006
Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrierShingo Ito, Sumio Ohtsuki, Tetsuya Terasaki
Pageof 23